Literature DB >> 18077722

CCL3 and viral chemokine-binding protein gg modulate pulmonary inflammation and virus replication during equine herpesvirus 1 infection.

Gerlinde R Van de Walle1, Kaori Sakamoto, Nikolaus Osterrieder.   

Abstract

CCL3 is a proinflammatory chemokine that mediates many of the cellular changes occurring in pulmonary disease. Here, CCL3(-/-) mice were used to investigate the role of this chemokine during respiratory herpesvirus infection. Compared to wild-type mice, CCL3(-/-) mice infected with the alphaherpesvirus equine herpesvirus 1 (EHV-1) displayed reduced body weight loss but had higher pulmonary viral loads. Lungs from infected CCL3(-/-) mice suffered a milder interstitial pneumonia, and fewer immune cells were recovered from the pulmonary airways after infection. We could also demonstrate that herpesvirus-encoded chemokine-binding glycoprotein G (gG) was capable of inhibiting the chemotactic functions of CCL3. This CCL3-mediated chemotaxis, however, was restored in the presence of gG-specific antibodies, which puts into question the advertised use of gG deletion mutants as marker vaccines. In summary, we concluded that CCL3 is a major player in controlling herpesvirus replication in the target organ, the lung, and does so by evoking a strong inflammatory response. The immunomodulatory activity of CCL3 is balanced by the expression of viral gG, whose chemokine-binding activity is mitigated in secondary infections by the production of anti-gG antibodies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18077722      PMCID: PMC2258710          DOI: 10.1128/JVI.02137-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Toxoplasma gondii inhibits toll-like receptor 4 ligand-induced mobilization of intracellular tumor necrosis factor alpha to the surface of mouse peritoneal neutrophils.

Authors:  Soumaya Bennouna; Woraporn Sukhumavasi; Eric Y Denkers
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

2.  In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette-Guérin is due principally to trehalose mycolates.

Authors:  Rachel E Geisel; Kaori Sakamoto; David G Russell; Elizabeth R Rhoades
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

3.  C-C chemokines, pivotal in protection against HIV type 1 infection.

Authors:  D Zagury; A Lachgar; V Chams; L S Fall; J Bernard; J F Zagury; B Bizzini; A Gringeri; E Santagostino; J Rappaport; M Feldman; S J O'Brien; A Burny; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

Review 4.  Chemokines and leukocyte traffic.

Authors:  M Baggiolini
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

Review 5.  Comparison of the pathogenesis of acute equine herpesvirus 1 (EHV-1) infection in the horse and the mouse model: a review.

Authors:  C Walker; D N Love; J M Whalley
Journal:  Vet Microbiol       Date:  1999-08-16       Impact factor: 3.293

6.  Infection with equine herpesvirus 1 (EHV-1) strain HVS25A in pregnant mice.

Authors:  C Walker; V M Perotti; D N Love; J M Whalley
Journal:  J Comp Pathol       Date:  1999-01       Impact factor: 1.311

7.  Expression of the full-length form of gp2 of equine herpesvirus 1 (EHV-1) completely restores respiratory virulence to the attenuated EHV-1 strain KyA in CBA mice.

Authors:  Patrick M Smith; Shannon M Kahan; Colin B Rorex; Jens von Einem; Nikolaus Osterrieder; Dennis J O'Callaghan
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

8.  Glycoprotein G deletion mutants of equine herpesvirus 1 (EHV1; equine abortion virus) and EHV4 (equine rhinopneumonitis virus).

Authors:  J Huang; C A Hartley; N P Ficorilli; B S Crabb; M J Studdert
Journal:  Arch Virol       Date:  2005-08-01       Impact factor: 2.574

9.  Primary and challenge infection of mice with equine herpesvirus 1, strain HSV25A.

Authors:  C Walker; P Packiarajah; J R Gilkerson; D N Love; J M Whalley
Journal:  Virus Res       Date:  1998-10       Impact factor: 3.303

10.  In situ study on the pathogenesis and immune reaction of equine herpesvirus type 1 (EHV-1) infections in mice.

Authors:  T Bartels; F Steinbach; G Hahn; H Ludwig; K Borchers
Journal:  Immunology       Date:  1998-03       Impact factor: 7.397

View more
  7 in total

Review 1.  Alphaherpesviruses and chemokines: pas de deux not yet brought to perfection.

Authors:  Gerlinde R Van de Walle; Keith W Jarosinski; Nikolaus Osterrieder
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

2.  In vitro characterization of EHV-4 gG-deleted mutant.

Authors:  Walid Azab; Abuelyazeed El-Sheikh; Azza Abdel-Gawad
Journal:  Virus Genes       Date:  2011-09-29       Impact factor: 2.332

3.  Gender affects IL-23 serum levels in the hospitalized COVID-19 infected patients.

Authors:  Mitra Abbasifard; Mohammad Kazemi Arababadi; Fatemeh Bahrehmand; Gholamreza Bazmandegan; Ziba Shabani Shahrbabaki; Zahra Kamiab
Journal:  Am J Clin Exp Immunol       Date:  2022-04-15

4.  Infectious Laryngotracheitis Virus Viral Chemokine-Binding Protein Glycoprotein G Alters Transcription of Key Inflammatory Mediators In Vitro and In Vivo.

Authors:  Mauricio J C Coppo; Joanne M Devlin; Alistair R Legione; Paola K Vaz; Sang-Won Lee; José A Quinteros; James R Gilkerson; Nino Ficorilli; Patrick C Reading; Amir H Noormohammadi; Carol A Hartley
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

5.  Effective treatment of respiratory alphaherpesvirus infection using RNA interference.

Authors:  Amy Fulton; Sarah T Peters; Gillian A Perkins; Keith W Jarosinski; Armando Damiani; Margaret Brosnahan; Elizabeth L Buckles; Nikolaus Osterrieder; Gerlinde R Van de Walle
Journal:  PLoS One       Date:  2009-01-05       Impact factor: 3.240

6.  A Live-Attenuated Equine Influenza Vaccine Stimulates Innate Immunity in Equine Respiratory Epithelial Cell Cultures That Could Provide Protection From Equine Herpesvirus 1.

Authors:  Lila M Zarski; Wendy E Vaala; D Craig Barnett; Fairfield T Bain; Gisela Soboll Hussey
Journal:  Front Vet Sci       Date:  2021-06-10

7.  Abortigenic but Not Neurotropic Equine Herpes Virus 1 Modulates the Interferon Antiviral Defense.

Authors:  Katrien C K Poelaert; Jolien Van Cleemput; Kathlyn Laval; Herman W Favoreel; Gisela Soboll Hussey; Roger K Maes; Hans J Nauwynck
Journal:  Front Cell Infect Microbiol       Date:  2018-09-12       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.